Unsupervised Clustering Successfully Predicts Prognosis in NSCLC Brain Metastasis Cohorts.

: Current developments in computer-aided systems rely heavily on complex and computationally intensive algorithms. However, even a simple approach can offer a promising solution to reduce the burden on clinicians. Addressing this, we aim to employ unsupervised cluster analysis to identify prognostic subgroups of non-small-cell lung cancer (NSCLC) patients with brain metastasis (BM). Simple-yet-effective algorithms designed to identify similar group characteristics will assist clinicians in categorizing patients effectively. : We retrospectively collected data from 95 NSCLC patients with BM treated at two oncology centers. To identify clinically distinct subgroups, two types of unsupervised clustering methods-two-step clustering (TSC) and hierarchical cluster analysis (HCA)-were applied to the baseline clinical data. Patients were categorized into prognostic classes according to the Diagnosis-Specific Graded Prognostic Assessment (DS-GPA). Survival curves for the clusters and DS-GPA classes were generated using Kaplan-Meier analysis, and the differences were assessed with the log-rank test. The discriminative ability of three categorical variables on survival was compared using the concordance index (C-index). : The mean age of the patients was 61.8 ± 0.9 years, and the majority (77.9%) were men. Extracranial metastasis was present in 71.6% of the patients, with most (63.2%) having a single BM. The DS-GPA classification significantly divided the patients into prognostic classes ( < 0.001). Furthermore, statistical significance was observed between clusters created by TSC ( < 0.001) and HCA ( < 0.001). HCA showed the highest discriminatory power (C-index = 0.721), followed by the DS-GPA (C-index = 0.709) and TSC (C-index = 0.650). : Our findings demonstrated that the TSC and HCA models were comparable in prognostic performance to the DS-GPA index in NSCLC patients with BM. These results suggest that unsupervised clustering may offer a data-driven perspective on patient stratification, though further validation is needed to clarify its role in prognostic modeling.